Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-618-7 | CAS number: 4430-18-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 3 September 2001 to 12 October 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- Version / remarks:
- according to OECD Environmental Health and Safety Publications, Series on Testing and Assessment No. 28. Draft guidance document for the conduct of skin absorption studies
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- Sodium 4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]toluene-3-sulphonate
- EC Number:
- 224-618-7
- EC Name:
- Sodium 4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]toluene-3-sulphonate
- Cas Number:
- 4430-18-6
- Molecular formula:
- C21H15NO6S.Na
- IUPAC Name:
- sodium 2-[(4-hydroxy-9,10-dioxo-9,10-dihydroanthracen-1-yl)amino]-5-methylbenzenesulfonate
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: supplied by l'Oreal, Batch No. 437/3, formulation used : batch No. 473219
- Expiration date of the lot/batch: not specified
- Purity test date: 4 October 2001
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: at room temperature, in absence of light and humidity
- Stability under test conditions: stable when stored but no details in test conditions
- Solubility and stability of the test substance in the solvent/vehicle: the test item was soluble at 100% in receptor fluid.
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
Formulated test item was provided by l'Oreal - Radiolabelling:
- no
Administration / exposure
- Type of coverage:
- open
- Vehicle:
- unchanged (no vehicle)
- Remarks:
- Formulation (components not described) containing 0.2% of test item
- Duration of exposure:
- 24 hours
- Doses:
- - Nominal doses: 0.2% in formulation
- Actual doses: 0.11%
- Actual doses calculated as follows: nominal dose x purity = actual dose
- Dose volume: 20mg/cm2
- Rationale for dose selection: no justification - No. of animals per group:
- 9 cells were used
- Control animals:
- no
- Details on study design:
- APPLICATION OF DOSE:
VEHICLE
- Amount(s) applied (volume or weight with unit): 20 mg/cm2
- Concentration (if solution): 0.2% of test item in formulation
- Lot/batch no. (if required): 473219
- Purity: not specified
REMOVAL OF TEST SUBSTANCE
- Washing procedures and type of cleansing agent: after 30 minutes of contact with distilled water, 2ml sodium lauryl sulfate aqueous solution, 3 cotton swabs to dry the skin
- Time after start of exposure: 30 minutes
SAMPLE PREPARATION
All skin biopsies were visually checked to ensure they were unaltered after clinical removal. After thawing, skin samples were dermatomed and cut into pieces of 2 cm X 2 cm ; their thickness was 380 ± 25 µm . Each skin sample was mounted in a diffusion cell, with an area of 2 cm2 and a receiver compartment of about 7 ml volume.
Skin samples were kept between two silicone membranes in order to maintain the cohesion with the cell compartments. The epidermal side of skin samples was exposed to the ambient conditions of the laboratory environment while the dermal side was in contact with the receptor fluid.
ANALYSIS
- Method type(s) for identification HPLC-MS-MS
- Validation of analytical procedure: validated by l'Oreal reported study
- Limits of detection and quantification: at 10 and 20 ng.mL in NaCI. - Details on in vitro test system (if applicable):
- SKIN PREPARATION
- Source of skin: esthetic surgery, no more details
- Ethical approval if human skin: not specified
- Type of skin: human skin
- Preparative technique: All skin biopsies were visually checked to ensure they were unaltered after clinical removal. After thawing, skin samples were dermatomed and cut into pieces of 2 cm X 2 cm ; their thickness was 380 ± 25 µm. Each skin sample was mounted in a diffusion cell, with an area of 2 cm2 and a receiver compartment of about 7 ml volume.
Skin samples were kept between two silicone membranes in order to maintain the cohesion with the cell compartments. The epidermal side of skin samples was exposed to the ambient conditions of the laboratory environment while the dermal side was in contact with the receptor fluid.
- Thickness of skin (in mm): 0.380 ± 0.025 µm
- Membrane integrity check: Approximately one hour after the skin was mounted in the diffusion cell, and just before the application of the formulation, the integrity of each skin sample was checked by measuring Trans Epidermal Water Loss (TEWL).
- Storage conditions: -18 deg Celsius
- Justification of species, anatomical site and preparative technique: no justification
PRINCIPLES OF ASSAY
- Diffusion cell: diffusion cell, with an area of 2 cm2 and a receiver compartment of about 7 ml volume.
- Receptor fluid: The receptor fluid used was NaCI 0.9% solution. The receptor fluid was continuously stirred by a small Teflon-covered stirring bar. Skin surface temperature was 31.5 ± 0.3°C ; it was maintained by thermostating the receptor solution
- Solubility of test substance in receptor fluid: the test item was soluble at 100% in receptor fluid.
- Static system: yes
- Flow-through system: no
- Test temperature: 31.5±0.3 deg Celsius
- Humidity: no
- Occlusion: open
- Reference substance(s): not performed
Results and discussion
- Absorption in different matrices:
- Skin excess represented the majority of the recovery of ACID VIOLET 43 with 104.22 % of the applied dose. Visual observation showed no skin staining after the washing procedure 30 minutes after application. Very low amounts of ACID VIOLET 43 were found in the stratum corneum. i.e. below 0.33 ± 0.20 % of the applied dose, demonstrating the absence of storage effect in this compartment. The epidermis + dermis represented only 0.23 ± 0.28 % of the applied dose demonstrating the very low absorption of this compound. No test compound was found in the receptor fluid, which confirms of very low absorption of ACID VIOLET 43. The concentration of ACID VIOLET 43 in the receptor fluid was below the detection limit for the 8 diffusion cells. Total skin + receptor fluid (SC + epidermis + dermis + RF) represented 0.56 ± 0.46 % of the applied dose. The absorbed amount (epidermis + dermis + RF) corresponded to 0.23 ± 0.28 % of the applied dose. Physicochemichal properties of ACID VIOLET 43, an hydrophilic compound (Log Poct/H2o = -0.12) with a rather high molecular weight (MW = 432.41) may explain the low absorbed amount obtained.
- Total recovery:
- Total recovery: Skin excess represented the majority of the recovery of ACID VIOLET 43 with 104.22 % of the applied dose.
- Recovery of applied dose acceptable: 80%
- Results adjusted for incomplete recovery of the applied dose: No
- Limit of detection (LOD): - at 1, 2.5 and 5 ng/ml in methanol/ammonium acetate buffer (50/50, v/v).; - at 10 and 20 ng/ml in NaCI.
- Quantification of values below LOD or LOQ: no quantification, expressed as "Below detection limit"
Any other information on results incl. tables
Table 1 :Summaryof theresults
|
Formulation 473219 |
Skin excess |
26.42 ± 2.50 |
Stratum corneum (SC) |
0.08 ± 0.05 |
Epidermis + dermis |
0.07 ± 0.06 |
Receptor fluid (RF) |
0.04±0.00 |
Total recovery |
105.12 ±3.06 |
Total skin + receptor fluid |
0.20±0.11 |
Absorbed amount (epidermis, dermis and receptor fluid) |
0.11±0.11 |
Applicant's summary and conclusion
- Conclusions:
- Under experimental conditions of this study, most of the test substance applied on the skin surface was removed with the washing procedure (about 104 % of the applied dose, in mean), and the total recovery rate was about 105 %. No test item Acid Violet 43 was measured in the receptor fluid. The mean absorbed amounts of test substance were estimated as follows: 0.11 ± 0.06 μg active dye/cm2 (0.53 ± 0.33 % of the applied dose). The no diffusion of the test item in receptor fluid showed a very low absoprtion of the test item.
- Executive summary:
In this GLP compliant in vitro study,the test item Ext. D&C Violet 2 was assessed for its potential to permeate human skin samples.
Human skin samples were obtained from four female donors subjected to plastic surgery. Skin samples (380 ± 25 μm in thickness) were dermatomed and mounted in diffusion cells, using 0.9% NaCl in water as a receptor fluid. Skin integrity was checked before application of the formulation by measuring Trans Epidermal Water Loss. After exposure period, the remaining formulation on the skin surface was removed using a standardized washing procedure. Twenty four hours after application, the percutaneous absorption of Jarocol Violet 43 was estimated by measuring its concentration by LC/MS/MS in the following compartments: skin excess, stratum corneum (isolated by tape strippings), epidermis + dermis and receptor fluid. The no diffusion of the test item in receptor fluid showed a very low absoprtion of the test item.
Most of the test substance applied on the skin surface was removed with the washing procedure (about 104 % of the applied dose, in mean), and the total recovery rate was about 105 %. No test item Acid Violet 43 was measured in the receptor fluid. The mean absorbed amounts of test substance were estimated as follows (sum of amounts measured in epidermis, dermis and receptor fluid when assuming concentrations at the detection limit in the receptor fluid of 40 ng): 0.11 ± 0.06 μg active dye/cm2 (0.53 ± 0.33 % of the applied dose). The no diffusion of the test item in receptor fluid showed a very low absorption of the test item.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.